论文部分内容阅读
目的:探讨除了血压水平危险分层外,不同亚临床靶器官损害的检测评估对高血压病患者心血管危险分层的影响。方法:258例住院高血压病患者,除了常规检测项目外,还进行心脏彩超及颈动脉内中膜层厚度的测量,依据2005年中国高血压防治指南,对血压水平及添加亚临床靶器官损害评估后的高血压病患者进行危险分层。结果:高血压病患者根据血压水平危险分层。低危60例(23.2%);中危115例(44.6%);高危83例(32.2%)。这些低中危的患者通过亚临床靶器官损害评估后再行危险分层,其高危组患者所占比率明显升高,为219例(84.9%),相比较血压水平危险分层具有明显的统计学差异(P<0.01)。结论:亚临床靶器官损害的检测评估可提高高血压病高危患者的检出率。
OBJECTIVE: To investigate the effects of different subclinical target organ damage assessment on cardiovascular risk stratification in hypertensive patients, except for the risk stratification of blood pressure levels. Methods: 258 inpatients with hypertension were enrolled in this study. In addition to the routine test items, the echocardiography and carotid intima-media thickness were measured. According to the 2005 guidelines for prevention and treatment of hypertension in China, the blood pressure level and the target organ damage Hypertensive patients were assessed for risk stratification. Results: Hypertensive patients were stratified according to their blood pressure levels. There were 60 cases (23.2%) with low risk, 115 cases (44.6%) with intermediate risk and 83 cases (32.2%) with high risk. These low- and intermediate-risk patients were assessed by sub-clinical target organ damage risk stratification, the proportion of patients with high-risk group increased significantly, 219 cases (84.9%), compared with the level of blood pressure risk stratification has obvious statistics Learning difference (P <0.01). Conclusion: The detection and evaluation of subclinical target organ damage can improve the detection rate of high risk patients with hypertension.